These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 12070033)

  • 1. Bethesda proposals for classification of nonlymphoid hematopoietic neoplasms in mice.
    Kogan SC; Ward JM; Anver MR; Berman JJ; Brayton C; Cardiff RD; Carter JS; de Coronado S; Downing JR; Fredrickson TN; Haines DC; Harris AW; Harris NL; Hiai H; Jaffe ES; MacLennan IC; Pandolfi PP; Pattengale PK; Perkins AS; Simpson RM; Tuttle MS; Wong JF; Morse HC;
    Blood; 2002 Jul; 100(1):238-45. PubMed ID: 12070033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bethesda proposals for classification of lymphoid neoplasms in mice.
    Morse HC; Anver MR; Fredrickson TN; Haines DC; Harris AW; Harris NL; Jaffe ES; Kogan SC; MacLennan IC; Pattengale PK; Ward JM;
    Blood; 2002 Jul; 100(1):246-58. PubMed ID: 12070034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.
    Vardiman JW; Thiele J; Arber DA; Brunning RD; Borowitz MJ; Porwit A; Harris NL; Le Beau MM; Hellström-Lindberg E; Tefferi A; Bloomfield CD
    Blood; 2009 Jul; 114(5):937-51. PubMed ID: 19357394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997.
    Harris NL; Jaffe ES; Diebold J; Flandrin G; Muller-Hermelink HK; Vardiman J; Lister TA; Bloomfield CD
    Ann Oncol; 1999 Dec; 10(12):1419-32. PubMed ID: 10643532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. A progress report.
    Jaffe ES; Harris NL; Diebold J; Muller-Hermelink HK
    Am J Clin Pathol; 1999 Jan; 111(1 Suppl 1):S8-12. PubMed ID: 9894466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The usefulness of immunophenotypic and genotypic studies in the diagnosis and classification of hematopoietic and lymphoid neoplasms. An update.
    Frizzera G; Wu CD; Inghirami G
    Am J Clin Pathol; 1999 Jan; 111(1 Suppl 1):S13-39. PubMed ID: 9894467
    [No Abstract]   [Full Text] [Related]  

  • 7. The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997.
    Harris NL; Jaffe ES; Diebold J; Flandrin G; Muller-Hermelink HK; Vardiman J; Lister TA; Bloomfield CD
    Histopathology; 2000 Jan; 36(1):69-86. PubMed ID: 10632755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion.
    Barbui T; Thiele J; Gisslinger H; Kvasnicka HM; Vannucchi AM; Guglielmelli P; Orazi A; Tefferi A
    Blood Cancer J; 2018 Feb; 8(2):15. PubMed ID: 29426921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The World Health Organization classification of hematological malignancies report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997.
    Harris NL; Jaffe ES; Diebold J; Flandrin G; Muller-Hermelink HK; Vardiman J; Lister TA; Bloomfield CD
    Mod Pathol; 2000 Feb; 13(2):193-207. PubMed ID: 10697278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data.
    Arber DA; Orazi A; Hasserjian RP; Borowitz MJ; Calvo KR; Kvasnicka HM; Wang SA; Bagg A; Barbui T; Branford S; Bueso-Ramos CE; Cortes JE; Dal Cin P; DiNardo CD; Dombret H; Duncavage EJ; Ebert BL; Estey EH; Facchetti F; Foucar K; Gangat N; Gianelli U; Godley LA; Gökbuget N; Gotlib J; Hellström-Lindberg E; Hobbs GS; Hoffman R; Jabbour EJ; Kiladjian JJ; Larson RA; Le Beau MM; Loh ML; Löwenberg B; Macintyre E; Malcovati L; Mullighan CG; Niemeyer C; Odenike OM; Ogawa S; Orfao A; Papaemmanuil E; Passamonti F; Porkka K; Pui CH; Radich JP; Reiter A; Rozman M; Rudelius M; Savona MR; Schiffer CA; Schmitt-Graeff A; Shimamura A; Sierra J; Stock WA; Stone RM; Tallman MS; Thiele J; Tien HF; Tzankov A; Vannucchi AM; Vyas P; Wei AH; Weinberg OK; Wierzbowska A; Cazzola M; Döhner H; Tefferi A
    Blood; 2022 Sep; 140(11):1200-1228. PubMed ID: 35767897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The World Health Organization (WHO) classification of tumors of the hematopoietic and lymphoid tissues: an overview with emphasis on the myeloid neoplasms.
    Vardiman JW
    Chem Biol Interact; 2010 Mar; 184(1-2):16-20. PubMed ID: 19857474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The myeloproliferative neoplasms: insights into molecular pathogenesis and changes in WHO classification and criteria for diagnosis.
    Anastasi J
    Hematol Oncol Clin North Am; 2009 Aug; 23(4):693-708. PubMed ID: 19577165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The World Health Organization (WHO) classification of the myeloid neoplasms.
    Vardiman JW; Harris NL; Brunning RD
    Blood; 2002 Oct; 100(7):2292-302. PubMed ID: 12239137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining the Boundary Between Myelodysplastic Syndromes and Myeloproliferative Neoplasms.
    Loghavi S; Wang SA
    Surg Pathol Clin; 2019 Sep; 12(3):651-669. PubMed ID: 31352979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Classification of neoplastic disorders of the haematopoietic system].
    Laeng RH; Lüthi U
    Ther Umsch; 2004 Feb; 61(2):69-77. PubMed ID: 15018389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting--Airlie House, Virginia, November, 1997.
    Harris NL; Jaffe ES; Diebold J; Flandrin G; Muller-Hermelink HK; Vardiman J; Lister TA; Bloomfield CD
    Hematol J; 2000; 1(1):53-66. PubMed ID: 11920170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.
    Harris NL; Jaffe ES; Diebold J; Flandrin G; Muller-Hermelink HK; Vardiman J; Lister TA; Bloomfield CD
    J Clin Oncol; 1999 Dec; 17(12):3835-49. PubMed ID: 10577857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Philadelphia chromosome-negative chronic myeloproliferative disease.
    Thiele J
    Am J Clin Pathol; 2009 Aug; 132(2):261-80. PubMed ID: 19605821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematopathology: integration of morphologic features and biologic markers for diagnosis.
    Jaffe ES
    Mod Pathol; 1999 Feb; 12(2):109-15. PubMed ID: 10071336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular tumor classification using DNA methylome analysis.
    Sill M; Plass C; Pfister SM; Lipka DB
    Hum Mol Genet; 2020 Oct; 29(R2):R205-R213. PubMed ID: 32657331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.